Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03765450 · ClinicalTrials.gov registry record
Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis
A clinical trial of Ulcerative Colitis, sponsored by Alimentiv.
- Active
- Registry status
- 18
- Enrollment target
- 3
- Study locations
NCT03765450 is a study of Ulcerative Colitis that is active but no longer recruiting, run by Alimentiv. The registered enrollment target is 18 participants, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT03765450, a study of Ulcerative Colitis, is active but no longer recruiting, sponsored by Alimentiv.
- ACTIVE NOT RECRUITING
- Registry status
- 18 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is an open-label, prospective, observational study with the primary objective to characterize the pharmacokinetics of infliximab in patients with Acute Severe Ulcerative Colitis.
Conditions Studied
Interventions
- DRUG Infliximab
Study Locations (3)
California
- UCSD - San Diego
New York
- Cornell University - New York
Ontario
- Mount Sinai Hospital - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-12-21 |
| Est. Completion | 2026-03-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03765450
The ClinicalTrials.gov registry entry for NCT03765450 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (99% lower). The listed sponsor is Alimentiv, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ulcerative Colitis appearing as the primary indexed condition, and to 1 intervention - of which Infliximab is the first listed.
NCT03765450 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, New York, Ontario.
Frequently Asked Questions
What is clinical trial NCT03765450 about?
NCT03765450 is a clinical study titled "Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis". This is an open-label, prospective, observational study with the primary objective to characterize the pharmacokinetics of infliximab in patients with Acute Severe Ulcerative Colitis.
What is the current status of trial NCT03765450?
This trial is currently active not recruiting. The enrollment target is 18 participants. The study started on 2018-12-21. Estimated completion is 2026-03-02.
What conditions does trial NCT03765450 study?
This clinical trial studies the following conditions: Ulcerative Colitis.
What interventions are being tested in trial NCT03765450?
The interventions under investigation include: Infliximab (DRUG).
Who is sponsoring clinical trial NCT03765450?
This trial is sponsored by Alimentiv, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03765450 being conducted?
This trial has 3 study locations across California, New York, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
RECRUITING · Phase 2
-
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
RECRUITING
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
RECRUITING · NA
-
Registry and Biorepository for IBD in Central Texas
RECRUITING
-
Nicotinamide Riboside in Ulcerative Colitis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.